FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Nephron Sterile Compounding Center Diltiazem HCl in 0 Recall

Diltiazem HCl in 0

Nephron Sterile Compounding Center LLC · West Columbia, SC

Risk level
Class II
Reported by FDA
Mar 8, 2023
Recall ID
D-0355-2023
Check your lot numberHow we source this data

Summary

Nephron Sterile Compounding Center recalled Diltiazem HCl in 0 starting Feb 22, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0355-2023 on Mar 8, 2023. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

Diltiazem HCl in 0.7% Sodium Chloride Injection, 125 mg/125 mL (1 mg/mL), 125 mL Single-Dose Container bottle, packaged in 15 x 1 IV Bottles per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-997-15.

Lot numbers, UPCs & expiration codes

Lots: DS2053, Exp. 2/27/2023

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0355-2023
Classification
Class II
Status
Terminated
Recall initiated
Feb 22, 2023
FDA report date
Mar 8, 2023
Quantity
4,743 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Nephron Sterile Compounding Center LLC

Original FDA data

Every field from FDA enforcement report D-0355-2023, exactly as published.

Show all FDA fields
City
West Columbia
State
SC
Status
Terminated
Country
United States
Event ID
91749
Address
4500 12th Street Ext
Code information
Lots: DS2053, Exp. 2/27/2023
Postal code
29172-3025
Report date
Mar 8, 2023
Product type
Drugs
Recall number
D-0355-2023
Classification
Class II
Recalling firm
Nephron Sterile Compounding Center LLC
Product quantity
4,743 bottles
Termination date
Sep 24, 2024
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Diltiazem HCl in 0.7% Sodium Chloride Injection, 125 mg/125 mL (1 mg/mL), 125 mL Single-Dose Container bottle, packaged in 15 x 1 IV Bottles per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-997-15.
Distribution pattern
Nationwide in the USA
Recall initiation date
Feb 22, 2023
Initial firm notification
Letter
Center classification date
Feb 27, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0355-2023, published Mar 8, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls